The industry has long recognized the promise of personalized medicine, with many new entrants in the last decade leading the way and offering molecular diagnostic services and comprehensive genomic testing for cancer and other diseases.
Forecasts of the total size of the personalized medicine market in 2025 range from $100 billion USD to over $2 trillion, due to varying definitions of the market, with most research firms estimating a CAGR of 10–11% over that time period.
Included in this Intelligence Brief:
- What personalized medicine is and how it will affect drug manufacturing protocols and healthcare costs
- What the current challenges are
- A review of personalized medicine in a number of disease areas
- Where the industry is heading
- What’s next for healthcare
